title: Effect of sodium restriction on platelet function in patients with essential hypertension.
abstract: The effects of sodium intake on blood pressure and platelet function were evaluated in 19 subjects with essential hypertension (10 men and 9 women; mean age 49.7 years). The study was conducted under 3 conditions: (1) normal sodium diet (12 g/day of salt was used in cooking), (2) after 5 days of mild sodium restriction diet (6 g/day of salt was used in cooking) and (3) after moderate sodium restriction (no salt was used in cooking). Blood pressure was significantly reduced following sodium restriction without any change in heart rate. The ratio of the plasma level of beta-thromboglobulin to platelet factor IV, regarded as the most reliable index for platelet activation in vivo, increased significantly after mild sodium restriction; this change was maintained after moderate sodium restriction. Plasma thromboxane B2, a stable metabolite of thromboxane A2, increased significantly after sodium restriction; the level of 6-ketoprostaglandin F1 alpha, a stable metabolite of prostacyclin, was unaffected. These results indicate that dietary sodium restriction induces both a reduction of blood pressure and an activation of platelet function in vivo. Thus, one must consider both antihypertensive effects and effects on platelet function as factors in adjusting the dietary sodium intake in the course of antihypertensive therapy.
authors.affiliation: Department of Nephrology, Kanto-Teishin Hospital, Tokyo, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Ikeda
authors.forename: T
authors.initials: T
authors.lastname: Gomi
authors.forename: J
authors.initials: J
authors.lastname: Sakurai
authors.forename: Y
authors.initials: Y
authors.lastname: Toya
authors.forename: K
authors.initials: K
authors.lastname: Fujinami
authors.forename: M
authors.initials: M
authors.lastname: Yuhara
authors.forename: F
authors.initials: F
authors.lastname: Ikegami
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood; D001792:Blood Platelets / Q000502:physiology*; D001794:Blood Pressure / Q000187:drug effects; D002118:Calcium / Q000032:analysis; D004039:Diet, Sodium-Restricted; D004837:Epinephrine / Q000097:blood; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000178:diet therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000097:blood; D010974:Platelet Aggregation / Q000187:drug effects; D012083:Renin / Q000097:blood; D012982:Sodium, Dietary / Q000494:pharmacology*; D013929:Thromboxane B2 / Q000097:blood; D001620:beta-Thromboglobulin / Q000032:analysis
chemical_list: D012982:Sodium, Dietary; D001620:beta-Thromboglobulin; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; D012083:Renin; D002118:Calcium; D009638:Norepinephrine; D004837:Epinephrine